Log-linear regression explains 63.4% of the cross-national variation in life expectancy through spending differences alone — a strong relationship given that many other social factors also matter. Each 2.7-fold increase in per-capita spending is associated with approximately 2.9 additional years of life expectancy (p=0). The standout outlier is Japan, which in 2020 spent $7,414 per capita but achieved only 87.3 years of life expectancy — below what its spending level would predict.

The scatter of all 357 country-year observations shows a clear positive association between spending and life expectancy (Pearson r = 0.504). However, the relationship is visibly curved: high-spending countries achieve only modest additional gains relative to mid-tier spenders, consistent with diminishing returns. Color-coding by country reveals that the USA cluster sits far to the right of all other nations while falling short of the life expectancy levels achieved by Japan and France.

Life expectancy has risen consistently across all 7 countries between 1970 and 2020. South Korea recorded the largest absolute gain of 19.6 years over the period, while USA improved by only 7.2 years. The convergence trend — with lower-starting countries gaining faster — suggests that healthcare investment delivers larger marginal returns at lower baseline levels.

Per-capita healthcare spending has grown dramatically across all countries, but the trajectories diverge sharply after the 1990s. USA saw the largest absolute increase of $21,358 per capita over the observation window. By 2020, USA leads at $21,720 per capita — roughly double the next-highest spender.

Plotting life expectancy against log(spending) reveals a near-linear relationship (R² = 63.4%), confirming that the raw data follows a logarithmic curve — i.e., diminishing returns. The regression slope is 2.9 years of life expectancy per unit of log-spending (p = 0), meaning each approximate tripling of spending is associated with roughly 3.2 additional years. Countries clustered tightly around the regression line get predictable returns; those far above it are efficiency leaders.

In 2020, Great Britain delivers the highest return: 13.82 years of life expectancy per $1,000 of per-capita healthcare spending. USA sits at the bottom with only 3.6 years per $1,000 — a 3.8x gap in healthcare efficiency. This ranking correlates inversely with absolute spending levels: countries that spend more tend to see lower efficiency ratios, again consistent with diminishing returns.

In 2020, Japan leads with 87.3 years of life expectancy, while USA trails at 78.3 years. The group average is 82.7 years. Notably, Japan — the highest spender — sits below the group average, illustrating that increased investment does not automatically translate into longer lives when structural inefficiencies or lifestyle factors are at play.

Across the full 1970–2020 panel, South Korea achieved the greatest life expectancy improvement: +19.55 years, accompanied by a $12,188 increase in per-capita spending. The table enables direct comparison of each country's efficiency trajectory — large spending increases paired with modest life expectancy gains signal diminishing returns, while small spending increases with large gains indicate efficient healthcare systems.